Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
Year: 2021
Type: erratum
Abstract: Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.
Source: Trials
Authors: Moses Badio, Edouard Lhomme, Mark Kieh, Abdoul Habib Beavogui, Stephen B. Kennedy, Seydou Doumbia, Bailah Leigh, Samba O. Sow, Alpha Diallo, Daniela Fusco, Matthew Kirchoff, Monique Termote, Renaud Vatrinet, Deborah Wentworth, Helène Esperou, H. Clifford Lane, Jerome Pierson, Deborah Watson-Jones, Céline Roy, Eric D’Ortenzio, Brian Greenwood, Genevieve Chêne, Laura Richer, James D. Neaton, Yazdan Yazdanpanah, the PREVAC study team
Institutions: Inserm, Centre Hospitalier Universitaire de Bordeaux, Bordeaux Population Health, Centre d'Investigation Clinique Plurithématique de Bordeaux, Université des Sciences, des Techniques et des Technologies de Bamako, University of Sierra Leone, Centre Pour le Développement des Vaccins-Mali, National Institute of Allergy and Infectious Diseases, Institut thématique Immunologie, inflammation, infectiologie et microbiologie, University of Minnesota, London School of Hygiene & Tropical Medicine, Assistance Publique – Hôpitaux de Paris, Hôpital Bichat-Claude-Bernard
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,290
OpenAlex ID: W4210454393